The methylation of certain CpG sites in the TLR2 promoter has been shown to reduce expression levels in natural killer cells/monocytes of patients with active pulmonary tuberculosis and correlates with bacterial load and disease severity [51]. The gene discussed is TLR2; the disease is pulmonary tuberculosis.